Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MacKay Holdings is a private investment and holding company primarily focused on the life sciences and biotechnology sectors. The company operates by identifying and investing in early-stage therapeutic opportunities, often providing both capital and strategic management to advance programs through the pre-clinical phase. Their portfolio typically spans a variety of therapeutic areas, including oncology and infectious diseases, with a focus on innovative modalities. MacKay Holdings often functions as an incubator for emerging biotech assets, aiming to bridge the gap between academic discovery and clinical development. The firm maintains a lean operational structure, leveraging a network of scientific advisors and contract research organizations to execute its development strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MacKay Holdings.